SavedAdd your journal

Journals / Retina-Vitreus / 2007 / Cilt: 15 - Sayı: 2

The role of hemorheologic factors in age related macular degeneration

Yaşa bağlı maküla dejenerasyonunda hemoreolojik faktörlerin rolü

Ramazan YAĞCI
Yusuf OFLU
Mesut ERDURMUŞ
Necati DEMİR
Nurten ÜNLÜ
Mustafa DURMUŞ
Sunay DUMAN
Pages
129–131
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This can play a role in the development of AMD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the role of plasma fibrinogen, hemoglobin, hematocrit, lipid and platelet levels in age related macular degeneration (AMD).
📊
Key Findings & Data:Materials and Methods: 30 patients with AMD and 29 healthy subjects as a control group were included in the study.
💡
Conclusion & Impact:This can play a role in the development of AMD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate the role of plasma fibrinogen, hemoglobin, hematocrit, lipid and platelet levels in age related macular degeneration (AMD). Materials and Methods: 30 patients with AMD and 29 healthy subjects as a control group were included in the study. Serum fibrinogen, hemoglobin, hematocrit, lipid and platelet counts were determined in two groups. Results: Serum fibrinogen level was 364.7±70.7 mg/dl in AMD group and 319.6±54.2 mg/dl in the control group. Fibrinogen levels were significantly higher in AMD group compared with control group (p<0.05). There was no statistically significant difference between two groups for the other parameters (p>0.05). Conclusion: Serum fibrinogen level is higher in patients with AMD. This can play a role in the development of AMD.

Özet

Amaç: Yaşa bağlı maküla dejenerasyonunda (YBMD) plazma fibrinojen, hemoglobin, hematokrit ve lipit düzeyleri ile trombosit sayısının etkisinin olup olmadığının araştırılması. Gereç ve Yöntem: Çalışmamıza 30 YBMD’si olan hasta ile kontrol grubu olarak 29 sağlıklı birey dahil edildi. Her iki grupta plazma fibrinojen düzeyi, hemoglobin, hematokrit ve lipit düzeyleri ile trombosit sayıları değerlendirildi. Bulgular: YBMD grubunda ortalama plazma fibrinojen düzeyi 364.7±70.7 mg/dl iken, kontrol grubunda 319.6±54.2 mg/dl idi. Fibrinojen düzeyleri kontrol grubu ile karşılaştırıldığında, YBMD grubunda anlamlı olarak daha yüksekti (p 0.05). Sonuç: Serum fibrinojeni, YBMD olan hastalarda daha yüksek olup, bu durum hastalığın oluşmasında rol oynayan faktörlerden biri olabilir

🔖

Cite This Article

YAĞCI, R., OFLU, Y., ERDURMUŞ, M., DEMİR, N., ÜNLÜ, N., DURMUŞ, M., DUMAN, S. (2007). The role of hemorheologic factors in age related macular degeneration. Retina-Vitreus, Cilt: 15 - Sayı: 2, 129–131. https://ajindex.com/articles/305252

References (15)

  1. Weih L, Van Newkirk MR, McCarty CA,et al.: Age-specific causes of bilateral visual impairment. Arch Ophthalmol. 2000;11 8:264-269
  2. Vingerling J, Klaver CCW, Hofman A, et al.: Epidemiology of age-related maculopathy. Epidemiol Rev. 1995;17:347-360
  3. Lip PL, Blann AD, Hope-Ross M, et al.: Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710 4. Bird AC.: Age related macular disease. Br J Ophthalmol. 1996;80:1-2
  4. Hyman LG, Lilienfeld AM, Ferris FL 3rd, et al.: Senile macular degeneration: a case-control study. Am J Epidemiol. 1 983;1 1 8:213-227
  5. Goldberg J, Flowerdew G, Smith E, et al.: Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700-710
  6. Vingerling JR, Dielemans I, Bots ML, et al.: Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol. 1995;142:404-409
  7. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986;104:216-219
  8. Kamış U, Okudan S, Özkağnıcı A.: Yaşa bağlı makula dejenerasyonunun oküler ve sistemik faktörler ile ilişkisi. T Oft Gaz. 2003;33:673-681
  9. The Eye Disease Case-Control Study Group: Risk factors for ne-ovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1708
  10. Klein R, Klein BE, Franke T.: The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1993;100:406-414
  11. Vinding T, Appleyard M, Nyboe J,et al.: Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. 1992;70:66-72
  12. Erakgün T, Nalçacı S, Menteş J, ve ark.: Eksüdatif tip yaşa bağlı makula dejeneresansında antioksidan indeks ve aterosklerotik risk faktör tayini. T Oft Gaz. 2003;33:278-284
  13. Blumenkranz MS, Russell SR, Robey MG, et al.: Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93:552-558 15. Klein BE, Klein R.: Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571-573
  14. Lip GYH.: Fibrinogen and cardiovascular disease. Q Med. 1995;88:155-165
  15. Lowe GDO.: Blood rheology in arterial disease. Clin Sci. 1986;71:13